Home | Welcome to Contract Pharma   
Last Updated Tuesday, October 21 2014
Print

McKinley Scientific, New Objective In Mass-Spec Pact



Published November 28, 2012
Related Searches: Development
McKinley Scientific and New Objective, Inc. have entered into a strategic co-marketing and development agreement aimed at expanding key applications for delivery of high-performance LC-MS systems. The agreement includes financing and support services for mass spectrometry provided by McKinley and New Objective’s nanospray front-end technologies.
 
Paul Corcoran, president and chief executive officer of McKinley Scientific, said, “New Objective and McKinley Scientific have enjoyed a close relationship for many years. It was a natural progression for us to combine our collective strengths into a mutually beneficial relationship. Our combined customer focus will yield broader and more powerful solutions with expanded choices, adaptability, and education opportunities. We are very excited to support Dr. Valaskovic along with the wonderful products and people at New Objective.”
 
Dr. Gary Valaskovic, the co-founder and president of New Objective, added, “I am very pleased to have strengthened and formalized the excellent, long standing relationship between New Objective and McKinley Scientific. The combination of New Objective’s world class front-end hardware and consumables, with the outstanding finance, sales, and support structure of McKinley Scientific is a winning combination for the customer, one that will enable the development of new markets for both organizations.”


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On